Skip to content

Clinical trials

Completed Phase 2/3 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2/3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20021
20041
20054
20061
20071
20141
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
NCIC Clinical Trials Group2
AHS Cancer Control Alberta1
Alpha Biopharma (Jiangsu) Co., Ltd.1
M.D. Anderson Cancer Center1
Medical Research Council1
Memorial Sloan Kettering Cancer Center1
Pierian Biosciences1
Post Graduate Institute of Medical Education and Research, Chandigarh1
Sanofi1
The Miriam Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms13
Carcinoma, Non-Small-Cell Lung6
Brain Neoplasms2
Breast Neoplasms1
Colorectal Neoplasms1
Cough1
Esophageal Neoplasms1
Heart Diseases1
Lung Diseases, Interstitial1
Lymphoma1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.